Cargando…
Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report
BACKGROUND: The understanding of coronavirus disease 2019 (COVID-19) is rapidly evolving. Although it is primarily a respiratory illness, other manifestations, such as Guillain-Barré syndrome, immune thrombocytopenia, and immune-mediated thrombotic thrombocytopenic purpura, have been described. We p...
Autores principales: | Tholin, Birgitte, Hauge, Marit Teigen, Aukrust, Pål, Fehrle, Lutz, Tvedt, Tor Henrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556888/ https://www.ncbi.nlm.nih.gov/pubmed/33054818 http://dx.doi.org/10.1186/s13256-020-02503-9 |
Ejemplares similares
-
Hemophagocytic lymphohistiocytosis and miliary tuberculosis in a previously healthy individual: a case report
por: Trovik, Linn Hereide, et al.
Publicado: (2020) -
Helmet mask and tocilizumab for a patient with hemophagocytic lymphohistiocytosis syndrome and COVID-19: a case report
por: Eroglu, Ahmet, et al.
Publicado: (2020) -
Hemophagocytic Lymphohistiocytosis
por: Kaçar, Ayşe Gonca, et al.
Publicado: (2022) -
Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis
por: Tesi, Bianca, et al.
Publicado: (2015) -
Limited efficacy of tocilizumab in adult patients with secondary hemophagocytic lymphohistiocytosis: a retrospective cohort study
por: Kim, Ju Yeon, et al.
Publicado: (2022)